BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 28277985)

  • 21. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells.
    Dou L; Jourde-Chiche N; Faure V; Cerini C; Berland Y; Dignat-George F; Brunet P
    J Thromb Haemost; 2007 Jun; 5(6):1302-8. PubMed ID: 17403109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic therapy with isosorbide-5-mononitrate causes endothelial dysfunction, oxidative stress, and a marked increase in vascular endothelin-1 expression.
    Oelze M; Knorr M; Kröller-Schön S; Kossmann S; Gottschlich A; Rümmler R; Schuff A; Daub S; Doppler C; Kleinert H; Gori T; Daiber A; Münzel T
    Eur Heart J; 2013 Nov; 34(41):3206-16. PubMed ID: 22555214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy.
    Ni R; Cao T; Xiong S; Ma J; Fan GC; Lacefield JC; Lu Y; Le Tissier S; Peng T
    Free Radic Biol Med; 2016 Jan; 90():12-23. PubMed ID: 26577173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Voluntary wheel running prevents salt-induced endothelial dysfunction: role of oxidative stress.
    Guers JJ; Kasecky-Lardner L; Farquhar WB; Edwards DG; Lennon SL
    J Appl Physiol (1985); 2019 Feb; 126(2):502-510. PubMed ID: 30571282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dehydroepiandrosterone protects against oxidative stress-induced endothelial dysfunction in ovariectomized rats.
    Camporez JP; Akamine EH; Davel AP; Franci CR; Rossoni LV; Carvalho CR
    J Physiol; 2011 May; 589(Pt 10):2585-96. PubMed ID: 21486789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats.
    Chinen I; Shimabukuro M; Yamakawa K; Higa N; Matsuzaki T; Noguchi K; Ueda S; Sakanashi M; Takasu N
    Endocrinology; 2007 Jan; 148(1):160-5. PubMed ID: 17023526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alpha2-adrenoceptors enhance angiotensin II-induced renal vasoconstriction: role for NADPH oxidase and RhoA.
    Jackson EK; Gillespie DG; Zhu C; Ren J; Zacharia LC; Mi Z
    Hypertension; 2008 Mar; 51(3):719-26. PubMed ID: 18250367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency.
    Vaziri ND; Dicus M; Ho ND; Boroujerdi-Rad L; Sindhu RK
    Kidney Int; 2003 Jan; 63(1):179-85. PubMed ID: 12472781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic intake of red wine polyphenols by young rats prevents aging-induced endothelial dysfunction and decline in physical performance: role of NADPH oxidase.
    Dal-Ros S; Zoll J; Lang AL; Auger C; Keller N; Bronner C; Geny B; Schini-Kerth VB
    Biochem Biophys Res Commun; 2011 Jan; 404(2):743-9. PubMed ID: 21167817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired vascular function in sepsis-surviving rats mediated by oxidative stress and Rho-Kinase pathway.
    de Souza P; Guarido KL; Scheschowitsch K; da Silva LM; Werner MF; Assreuy J; da Silva-Santos JE
    Redox Biol; 2016 Dec; 10():140-147. PubMed ID: 27744119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.
    Gao L; Mann GE
    Cardiovasc Res; 2009 Apr; 82(1):9-20. PubMed ID: 19179352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NADPH oxidase-derived reactive oxygen species contribute to impaired cutaneous microvascular function in chronic kidney disease.
    DuPont JJ; Ramick MG; Farquhar WB; Townsend RR; Edwards DG
    Am J Physiol Renal Physiol; 2014 Jun; 306(12):F1499-506. PubMed ID: 24761000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tempol-nebivolol therapy potentiates hypotensive effect increasing NO bioavailability and signaling pathway.
    Bertera FM; Santa-Cruz DM; Balestrasse KB; Gorzalczany SB; Höcht C; Taira CA; Polizio AH
    Free Radic Res; 2014 Feb; 48(2):109-18. PubMed ID: 24074298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of a RhoA/ROCK-Dependent Pathway on Renal Connexin43 Regulation in the Angiotensin II-Induced Renal Damage.
    Gómez GI; Velarde V; Sáez JC
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tempol, a Superoxide Dismutase-Mimetic Drug, Ameliorates Progression of Renal Disease in CKD Mice.
    Ding W; Wang B; Zhang M; Gu Y
    Cell Physiol Biochem; 2015; 36(6):2170-82. PubMed ID: 26279424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased reactive oxygen species production and NOX1, NOX2, NOX4 expressions contribute to hyporeactivity to phenylephrine in aortas of pregnant SHR.
    Troiano JA; Potje SR; Graton ME; Cavalari P; Pereira AA; Vale GT; Nakamune AC; Sumida DH; Tirapelli CR; Antoniali C
    Life Sci; 2016 Jan; 144():178-84. PubMed ID: 26674464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral adsorbent AST-120 ameliorates endothelial dysfunction independent of renal function in rats with subtotal nephrectomy.
    Namikoshi T; Tomita N; Satoh M; Sakuta T; Kuwabara A; Kobayashi S; Higuchi Y; Nishijima F; Kashihara N
    Hypertens Res; 2009 Mar; 32(3):194-200. PubMed ID: 19262482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sinomenine alleviates high glucose-induced renal glomerular endothelial hyperpermeability by inhibiting the activation of RhoA/ROCK signaling pathway.
    Yin Q; Xia Y; Wang G
    Biochem Biophys Res Commun; 2016 Sep; 477(4):881-886. PubMed ID: 27378427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Could pharmacological curtailment of the RhoA/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?
    Eisa-Beygi S; Wen XY
    Antiviral Res; 2015 Feb; 114():53-6. PubMed ID: 25512227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
    Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
    Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.